Study of Safety and Immunogenicity of BVRS-GamVac

Conditions:   MERS (Middle East Respiratory Syndrome);   MERS Interventions:   Biological: BVRS-GamVac;   Other: placebo Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials